1. Home
  2. GIS vs GNLX Comparison

GIS vs GNLX Comparison

Compare GIS & GNLX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo General Mills Inc.

GIS

General Mills Inc.

N/A

Current Price

$48.62

Market Cap

25.5B

ML Signal

N/A

Logo Genelux Corporation

GNLX

Genelux Corporation

N/A

Current Price

$4.19

Market Cap

202.4M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
GIS
GNLX
Founded
1866
2001
Country
United States
United States
Employees
N/A
N/A
Industry
Packaged Foods
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Staples
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
25.5B
202.4M
IPO Year
N/A
2023

Fundamental Metrics

Financial Performance
Metric
GIS
GNLX
Price
$48.62
$4.19
Analyst Decision
Hold
Strong Buy
Analyst Count
16
4
Target Price
$54.19
$19.75
AVG Volume (30 Days)
6.8M
168.1K
Earning Date
12-17-2025
11-05-2025
Dividend Yield
5.02%
N/A
EPS Growth
0.65
N/A
EPS
4.63
N/A
Revenue
$18,776,700,000.00
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
$10.51
N/A
Revenue Growth
N/A
N/A
52 Week Low
$45.15
$1.99
52 Week High
$67.35
$8.54

Technical Indicators

Market Signals
Indicator
GIS
GNLX
Relative Strength Index (RSI) 63.23 35.80
Support Level $46.65 $4.00
Resistance Level $46.31 $4.75
Average True Range (ATR) 0.84 0.38
MACD 0.23 -0.03
Stochastic Oscillator 89.79 10.58

Price Performance

Historical Comparison
GIS
GNLX

About GIS General Mills Inc.

General Mills is a global packaged-food company that produces snacks, cereal, convenient meals, dough, baking mixes and ingredients, pet food, and superpremium ice cream. Its largest brands are Nature Valley, Cheerios, Old El Paso, Pillsbury, Betty Crocker, Blue Buffalo, and Haagen-Dazs. In fiscal 2025, 81% of its revenue was derived from the United States, although the company also operates in Canada, Europe, Australia, Asia, and Latin America. Although most of General Mills' products are sold through retail stores to consumers, the company also sells products to the foodservice channel and the commercial baking industry.

About GNLX Genelux Corporation

Genelux Corp is a clinical-stage biopharmaceutical company. The company focuses on developing next-generation oncolytic viral immunotherapies for patients suffering from aggressive or difficult-to-treat solid tumor types. Its pipeline products include Olvi-Vec (olvimulogene nanivacirepvec), Lung, and Pancreatic Cancer.

Share on Social Networks: